ENTRY       H01422                      Disease
NAME        Carbapenem-resistant bacterial infection
  SUBGROUP  Carbapenem-resistant Enterobacteriaceae (CRE) infection
            Carbapenem-resistant Pseudomonas aeruginosa infection
            Carbapenem-resistant Acinetobacter baumannii infection
DESCRIPTION Carbapenems [DG:DG01458] are a class of beta-lactam antibiotics often used as the last resort treatment for severe bacterial infections. Thus, the appearance of carbapenem resistance caused by acquisition of carbapenem-hydrolyzing beta-lactamases (carbapenemases), especially among Enterobacteriaceae, Pseudomonas and Acinetobacter, is considered as a global health threat.
CATEGORY    Infectious disease
BRITE       Infectious diseases [BR:br08401]
             Bacterial infections
              Infections caused by bacteria
               H01422  Carbapenem-resistant bacterial infection
            Human diseases in ICD-11 classification [BR:br08403]
             21 Symptoms, signs or clinical findings, not elsewhere classified
              General symptoms, signs or clinical findings
               Finding of microorganism resistant to antimicrobial drugs
                MG50  Finding of gram negative bacteria resistant to antimicrobial drugs
                 H01422  Carbapenem-resistant bacterial infection
PATHOGEN    Enterobacteriaceae
            Pseudomonas
            Acinetobacter
  MODULE    M00851  Carbapenem resistance
DBLINKS     ICD-11: MG50.02 MG50.24 MG50.92 MG50.A0 MG50.C0
            ICD-10: U82.8
REFERENCE   PMID:24360201
  AUTHORS   Nordmann P
  TITLE     Carbapenemase-producing Enterobacteriaceae: overview of a major public health challenge.
  JOURNAL   Med Mal Infect 44:51-6 (2014)
            DOI:10.1016/j.medmal.2013.11.007
REFERENCE   PMID:21859938
  AUTHORS   Papp-Wallace KM, Endimiani A, Taracila MA, Bonomo RA
  TITLE     Carbapenems: past, present, and future.
  JOURNAL   Antimicrob Agents Chemother 55:4943-60 (2011)
            DOI:10.1128/AAC.00296-11
///
